Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jul 7, 2026
- Accession no.
- 0001106578-26-000092
- Filed
- Jul 7, 2026, 9:10 AM ET
- Trade date
- Jul 6, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.22M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Common Stock | MOption exerciseAcquired | +9,500 | $135.42 | +$1,286,490 | 50,013 | Direct | |
| Jul 6, 2026 | Common Stock | SSaleDisposed | −2,098 | $546.93F2 | −$1,147,467.74 | 47,915 | Direct | |
| Jul 6, 2026 | Common Stock | SSaleDisposed | −1,031 | $548.00F3 | −$564,988 | 46,884 | Direct | |
| Jul 6, 2026 | Common Stock | SSaleDisposed | −3,354 | $549.03F4 | −$1,841,458.69 | 43,530 | Direct | |
| Jul 6, 2026 | Common Stock | SSaleDisposed | −2,116 | $549.87F5 | −$1,163,514.76 | 41,414 | Direct | |
| Jul 6, 2026 | Common Stock | SSaleDisposed | −329 | $550.78F6 | −$181,205.14 | 41,085 | Direct | |
| Jul 6, 2026 | Common Stock | SSaleDisposed | −131 | $551.88F7 | −$72,296.88 | 40,954 | Direct | |
| Jul 6, 2026 | Common Stock | SSaleDisposed | −135 | $553.39F8 | −$74,707.35 | 40,819 | Direct | |
| Jul 6, 2026 | Common Stock | SSaleDisposed | −306 | $553.90F9 | −$169,494.81 | 40,513 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 58,718 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $546.43 to $547.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $547.465 to $548.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $548.47 to $549.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $549.47 to $550.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $550.51 to $551.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $551.52 to $552.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $552.59 to $553.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $553.695 to $554.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.